NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/03/2024
Voltar para busca
Dado oficial do USPTO
LEVITASBIO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
LEVITASBIO
ST13
US500000090439943Classe
1, 5, 9, 10, 42
Pedido
90439943
Registro
7323147
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
52
Atualização mais recente
05/03/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9, 10, 42
Data de depósito
31/12/2020
Data de registro
05/03/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/03/2024
Última transação
05/03/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Primeiro uso
18/01/2022
Primeiro uso no comércio
18/01/2022
Código do desenho
4
Tipo de titular
03
Localização do titular
MENLO PARK, CA
Examinador
CASE, LEIGH
Unidade examinadora
M30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
LEVITASBIO, INC.
Levitas, Inc.
Representantes
Jason Sanders Sanders IP Law
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 10Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Reagentscartridges and testing kits comprised of medical diagnostic reagents and assays for testing cell gene expression and cell data for scientific and research purposes; testing kitschemical preparationscompoundsenzymesfluids sold together as a unit for scientific and research purposes
Classe 5
Reagentscartridges and testing kits comprised of medical diagnostic reagents and assays for testing cell gene expression and cell data for medical diagnostic use; Testing kitschemical preparationscompoundsenzymesfluids sold together as a unit for medical diagnostic purposes
Classe 9
Scientific equipmentdevices for analyzing nucleic acidsfor RNA and DNA analysisfor DNA sequencing for the purpose of performing scientific researchdownloadable software for use therewith sold as a unit; medical diagnostic apparatus for high-speed analysis for assessing cells for the purpose of performing scientific research
Classe 10
Medical equipmentdevices for analyzing nucleic acidsfor RNA and DNA analysisfor DNA sequencing for the purpose of providing medical treatment and diagnosisdownloadable software for use therewith sold as a unit; medical diagnostic apparatus for high-speed analysis for assessing cells for the purpose of providing medical treatment and diagnosis
Classe 42
Scientific and laboratory researchdevelopmentconsultingdesignengineering and testing services in the fields of biotechnologypharmaceuticalscomputer sciencechemistrybiochemistrybiologygeneticsgenotyping and forensic sciences; Scientific research featuring the analysisdetection and isolation of biological substances in samples in the fields of geneticsgenotypingDNA analysis and pharmacogenetics
Publicações
Histórico de despachos e eventos da marca no USPTO.
52 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
05/03/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
27/01/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
26/01/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/01/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/01/2024
EX2G
SOU EXTENSION 2 GRANTED
05/01/2024
IUAF
USE AMENDMENT FILED
03/01/2024
NREV
NOTICE OF REVIVAL - E-MAILED
03/01/2024
EISU
TEAS STATEMENT OF USE RECEIVED
03/01/2024
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
03/01/2024
PETG
PETITION TO REVIVE-GRANTED
03/01/2024
PROA
TEAS PETITION TO REVIVE RECEIVED
03/01/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
28/12/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
28/12/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
28/12/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
28/12/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
28/12/2023
EXT2
SOU EXTENSION 2 FILED
13/12/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/07/2023
EX1G
SOU EXTENSION 1 GRANTED
30/06/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
20/06/2023
EXT1
SOU EXTENSION 1 FILED
13/06/2023
EEXT
SOU TEAS EXTENSION RECEIVED
13/06/2023
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
13/06/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
13/12/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18/10/2022
PUBO
PUBLISHED FOR OPPOSITION
18/10/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/09/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/09/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/08/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/08/2022
ALIE
ASSIGNED TO LIE
29/08/2022
NREV
NOTICE OF REVIVAL - E-MAILED
19/08/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
19/08/2022
PETG
PETITION TO REVIVE-GRANTED
19/08/2022
PROA
TEAS PETITION TO REVIVE RECEIVED
19/08/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
18/02/2022
GNRT
NON-FINAL ACTION E-MAILED
18/02/2022
CNRT
NON-FINAL ACTION WRITTEN
18/02/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/02/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/02/2022
ALIE
ASSIGNED TO LIE
27/01/2022
ALIE
ASSIGNED TO LIE
17/01/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/01/2022
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
20/10/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
13/07/2021
GNRT
NON-FINAL ACTION E-MAILED
13/07/2021
CNRT
NON-FINAL ACTION WRITTEN
13/07/2021
DOCK
ASSIGNED TO EXAMINER
07/07/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/03/2021
NWAP
NEW APPLICATION ENTERED
04/01/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LEVITASBIO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.